Please provide your email address to receive an email when new articles are posted on . HPV-based vs. cytology-based screening was tied to lower risks for invasive cervical cancer. Adverse events were ...
HHS’s Health Resources and Services Administration released updated guidance for cervical cancer screening, which includes a ...
“HPV DNA testing is proven to be more effective in detecting precancerous changes of the cervix compared to conventional pap ...
Hence, it is advisable to start screening from 3 years after the first sexual intercourse. The western medical literature ...
Recently the FDA approved the BD Onclarity HPV assay as a test to identify HPV high-risk genotypes in addition to HPV 16 and 18 i.e., extended genotyping). The Onclarity assay is designed to identify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback